![Seonghwan Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seonghwan Lee
Direttore/Membro del Consiglio presso Orange Grove Bio LLC
Posizioni attive di Seonghwan Lee
Società | Posizione | Inizio | Fine |
---|---|---|---|
SV Investment Corp/US/ | Investitore di Private Equity | 01/03/2020 | - |
Orange Grove Bio LLC
![]() Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Direttore/Membro del Consiglio | 01/11/2022 | - |
Storia della carriera di Seonghwan Lee
Formazione di Seonghwan Lee
Yonsei University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Corea del Sud | 2 |
Posizioni
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Private Equity Investor | 1 |
Settori
Consumer Services | 3 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Orange Grove Bio LLC
![]() Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Finance |
SV Investment Corp/US/ | Finance |
- Borsa valori
- Insiders
- Seonghwan Lee
- Esperienza